Med Chem - Venous Thromboembolism + Anticoagulants Flashcards

1
Q

causes of clots

A

injury to vasculature, tissue, blood hypercoaguability, blood stasis (not moving)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

3 general steps to coagulation

explain them

A

-platelet adhesion - platelets adhere to injured cells and tissue

-platelet aggregation - platelets adhere TO EACH OTHER under influence of TxA2 (released from platelet)

-blood coagulation - strengthens the “plug” of platelets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

3 steps of blood coagulation

A
  1. generation of factor x (intrinsic and extrinsic)
  2. thrombin formation (from prothrombin)
  3. fibrin formation (from fibrinogen)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

name the 5 major classes of anticoagulants

A

vitamin k antagonists

heparins

direct factor Xa inhibitors

direct thrombin inhibitors

antiplatelet drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

name the 2 chemical classes of vitamin K antagonists

A

coumarins
1,3-inandiones

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

how were coumarins discovered as anticoagulants

A

naturally - from cattle who were fed fermented hay - they got a bleeding disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

**which isomer of warfarin is more active

A

the S isomer is 4x more active

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

explain the mechanism of action of coumarins***

A

they are competitive inhibitors of BOTH vitamin K reductase AND vitamin K epoxide reductase

this results in inhibition of vitamin-K dependent carboxylation of proenzymes – LEADING TO REDUCED COAGULATION FACTORS SUCH AS II (prothrombin), VII, IX, and X

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

name the 4 coagulation factors that coumarins reduce the numbers of

A

II (prothrombin), VII, IX, X

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

true or false

warfarin is 100% metabolized to inactive metabolites

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

***what are the R and S isomers of warfarin metabolized by

A

S isomer - majorly by CYP2C9

R isomer - by 3A4, 2C19, 1A2

introduce OH groups

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

polymorphisms in which CYP enzyme can affect the metabolism of warfarin

A

2c9

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

2 drugs that are 1,3-indandione vitamin K antagonists

A

phenindione
anisidione

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

true or false

1,3-indandiones have more pharmacological activity than coumarins

A

TRUE - they are also analgesics, uricosuric, anti-inflamm, etc

HOWEVER, warfarin is still preferred over them bc they have singnificant renal and hepatic toxicities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

***unfractionated heparin s a polysaccharide composed of sulfated D-glucosamine and D-glucuronic acid residues LINKED BY ________

A

alpha 1,4 bonds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

unfractionated heparins are highly _____ in nature

they are similar to what other molecule(s)?

A

HIGHLY acidic

hyaluronic acid, chondroitin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

explain the dual MOA of unfractionated heparin

A

antithrombin III (AT) is formed in the liver. it slowly inactivates thrombin

heparin binds to AT causing a conformational change in AT

this conformational change causes ACCELERATED BINDING to thrombin (MOA1) AND to Factor Xa (MOA2)

heparin is then released from the complex leaving behind an inactive form of thrombin/Xa – therefore heparin is a catalyst — can leave and do the process again by binding another antithrombin III

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

HOW does heparin bind to AT (what specific bonds)

A

by its anionic COO- and SO3- to the cationic aa’s (lysine and arginine) in AT

19
Q

2 ways heparin can be administered

A

subq or IV

NOT IM (hematomas) or oral - degraded by gastric acid

20
Q

MAJOR ADR of heparin

A

THROMBOCYTOPENIAS

Type 1 - non immune (HAT - heparin associated thrombocytopenia)

type 2 - immune (LIFE THREATENING) - HIT (heparin induced thrombocytopenia)

21
Q

**3 major drugs that are low MW heparins

A

enoxaparin
dalteparin
tinzaparin

22
Q

**all 3 low MW heparins show slight selectivity for…

which has highest ratio? which has lowest?

A

ALL have higher selectivity for Xa inhibition over thrombin

enoxaparin has highest for Xa

tinzaparin has lowest, but still more than thrombin

23
Q

how are low molecular weight heparins produced

A

from heparin by chemical or enzymatic depolymerization

24
Q

3 major advantages of low molecular weight heparin over unfractionated heparin

A

-lower incidence of HIT - bc more selective for Xa

-longer half life - only need q12

-predictable dose response - so no need to monitor aPTT (activated partial thromboplastin time)

25
Q

name 4 factor Xa inhibitors

A

fondaparinux
rivaroxaban
apixaban
edoxaban

26
Q

**briefly explain the structure of fondaparinux

A

a synthetic pentasaccharide (5 sugars) + an OCH3 group at the reducing end

27
Q

**incidence of HIT in fondaparinux

A

even lower incidence of HIT than the low molecular weight heparins!!

28
Q

while there is a lower risk of HIT in fondaparinux than LMWH’s, however….

A

fondaparinux has a risk of thromboembolic issues when used for epidural or spinal hemotoma

can get long term/permanent paralysis :(

29
Q

3 indications for rivaroxaban (xarelto)

A

-prevention venous thromboembolism in pts undergone total hip replacement and knee replacement

-prevention stroke and systemic embolism in pts with afib

-TREATMENT DVT and PE

30
Q

xarelto is not recommended for use in what patients

A

severe renal issues (cr crl less than 30)

31
Q

2 indications for apixaban

A

-reduce risk of stroke and systemic embolism in a fib

-lower risk venous thromboembolism post orthopedic surgery

32
Q

2 indications for edoxaban

A

-reduce risk stroke and systemic embolism in pts with non valvular a fib
-lower risk of venous thrombosis post orthopedic surgery

33
Q

which are hydrolyzed faster – esters or amides

A

esters much faster

34
Q

***name 6 direct thrombin inhibitors

A

hirudin
lepirudin
desirudin
bivalirudin
argatroban
dabigatran (NOAC)

35
Q

**name 1 direct thrombin inhibitor that is REVERSIBLE and 2 that are IRREVERSIBLE

A

reversible - hirudin

irreversible - lepirudin, desirudin

36
Q

explain the MOA of hirudin

A

forms non covalent stable complex with alpha thrombin.
(REVERSIBLE inhibition)

therefore, thrombin can’t cleave fibrinogen and initiate the clotting cascade!

37
Q

MOA bivalirudin

A

direct thrombin inhibitor

works by binding BOTH the catalytic site and the allosteric site (anionic-binding exosite I) of thrombin

38
Q

argatroban is synthetic or natural?

A

synthetic thrombin inhibitor

derived from L-arginine (has highly basic guanidine gorup!!!!!****

39
Q

how is argatroban able to exert anticoagulation effects

A

inhibits thrombin-catalyzed reactions like fibrin formation, activation of coagulation facotrs (5,8,13), protein C, platelet aggregation

40
Q

indication for argatroban

A

for prevention or treatment of thrombosis in patients with HIT

41
Q

2 indications for dabigatran

A

-prevent venous thromboembolism in pts underwent hip or knee replacement

-prevent stroke and embolism in pts with a fib

42
Q

3 contraindications to dabigatran

A

-severe renal impairment (cr cl <30)

-concimitant tratment w p-glycoprotein inhibitors

-mechanical or prosthetic heart valves

43
Q
A